Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
107 studies found for:    Open Studies | "Diabetic Foot"
Show Display Options
Rank Status Study
1 Recruiting The Pharmacokinetic Study of WH-1 Ointment in Subjects With Chronic Diabetic Foot Ulcers
Condition: Diabetic Foot
Intervention: Drug: WH-1 ointment
2 Recruiting Evaluate the Efficacy and Safety of WH-1 Ointment for the Treatment of Chronic Diabetic Foot Ulcers
Condition: Diabetic Foot
Interventions: Drug: WH-1 ointment;   Other: Aquacel® Hydrofiber® dressing
3 Recruiting BioimPEDance of Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcer
Intervention: Other: Foot ulcer impedance
4 Not yet recruiting Management of the Diabetic Foot Using Electrolysed Water
Condition: Diabetic Foot
Interventions: Other: Electrolysed water;   Other: Prontosan
5 Recruiting Study of ReCell® Treating for Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcer
Interventions: Device: ReCell®;   Procedure: skin graft
6 Recruiting White Blood Cell SPECT/CT and Diabetic Foot Osteomyelitis
Condition: Diabetic Foot Osteomyelitis
Intervention: Other: white blood cell SPECT/CT (Single Photon Emission Computed Tomography/Computed Tomography) imaging
7 Not yet recruiting Can Topical Oxygen Therapy (Natrox™) Improve Wound Healing in Diabetic Foot Ulcers?
Condition: Diabetic Foot
Intervention: Device: Natrox™ Oxygen Delivery System (ODS)
8 Recruiting Safety and Efficacy Study of Neovasculgen (Pl-VEGF165) Gene Therapy in Patients With Diabetic Foot
Condition: Ulcers Related to Diabetic Foot Syndrome
Intervention: Drug: Neovasculgen
9 Recruiting Topical Oxygen Therapy for Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcers
Intervention: Device: Topical Oxygen Chamber for Extremities
10 Not yet recruiting A Prospective, Randomized Clinical Trial of ECLIPSE PRP™ Wound Biomatrix in Non-Healing Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcers
Interventions: Device: Eclipse PRP™ Wound Biomatrix;   Other: Usual and Customary Practice
11 Not yet recruiting The Use of Allogenic Platelet Rich Plasma for the Treatment of Diabetic Foot Ulcer
Condition: Diabetic Foot Ulcer
Interventions: Biological: Platelet Lysate;   Biological: Platelet Poor Plasma
12 Recruiting Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcers
Intervention: Drug: Granexin® gel
13 Recruiting A Comparative Efficacy Study of DermaPure™ to Treat Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcers
Interventions: Other: DermaPure™;   Other: Standard care
14 Recruiting WEMR With Clinical Decision Support for Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcers
Intervention:
15 Recruiting A Study of Granexin Gel to Treat Diabetic Foot Ulcer
Condition: Diabetic Foot Ulcers
Interventions: Drug: Granexin gel;   Drug: Vehicle gel
16 Recruiting A Study of Granexin Gel in the Treatment of Diabetic Foot Ulcer
Condition: Diabetic Foot Ulcers
Interventions: Drug: Granexin gel;   Other: Vehicle gel
17 Recruiting Clinical Efficacy of Platelet Gel From Cord Blood for the Treatment of Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcers
Interventions: Biological: Allogeneic cord blood platelet gel-CBPG;   Other: Standard Local Medications-SLM
18 Recruiting VA MERIT: A Comparative Efficacy Study: Treatment of Non-Healing Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcer
Interventions: Device: SECONDARY dressing gauze and tape;   Procedure: debridement, irrigation;   Device: Dermagraft™;   Device: Oasis™
19 Recruiting Evaluation of Woulgan in Diabetic Foot Ulcer
Condition: Diabetic Foot Ulcers
Interventions: Device: Woulgan Gel;   Device: Intrasite Hydrogel
20 Recruiting The Role of Telemedical Monitoring in Diabetic Foot Ulcer Care
Condition: Diabetic Foot - Telemedical Monitoring
Interventions: Device: telemedical monitoring ( T);   Device: classic monitoring

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.